Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my fellow members of the “mainstream media.”
The drug industry developed five vaccines in one year for COVID-19, a disease associated with the deaths of 3.7 million people world-wide. Alzheimer’s treatments? Oh, one for every 20 years. Even Biogen itself had substantially underperformed the broader stock market index for a decade. Until Monday. This is nuts. Maybe the new treatment makes things better, maybe it doesn’t. Apparently people aren’t certain. It’s hardly a surprise: The treatment is new, and the disease is complicated. But the first question to ask isn’t whether it makes things better, but whether it makes things worse. The current situation is catastrophic for anyone with the disease. People are dying. Lives are being destroyed.
A look through the Biogen’s public filings tells the sorry story. This new Alzheimer’s treatment entered Phase 3 trials in 2015—six years ago. Did I mention it took one year to get COVID vaccines to market?
How about ask the right question… like how did it get FDA approval when there is no conclusive evidence, as confirmed by the advisory panel, that it actually slows memory loss / mental decline? 3 panel members have resigned in protest. FACT
There's no money in cures.
It’s the way of the world, it’s called sod tomorrow enjoy today.
WTH is going on with ORPH (Orphazyme), 1,140% jump in just few hours?
I love when MarketWatch people realize that human beings are unethical and irrational.
Why do we put carcinogens in dryer sheets? A study suggests scented laundry items contain carcinogens that waft through vents, potentially raising cancer risk. A carcinogen a substance, radionuclide, or radiation that promotes the formation of cancer.
I thought there was a new drug for this
Pictured: Brett Arends
Yep. It’s called CAPITALISMA and it works. Or you can choose die in cointrys with no greed at all like north korea, cuba, etc.
hell ya
Same price as they charge in the EU or India
Just normalize higher multiples for promising biotech stocks. They deserve it